Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring.
The possible existence of an increased susceptibility to the reinforcing properties of morphine was analyzed in male and female rats born from mothers exposed to delta9-tetrahydrocannabinol (THC, 1, 5, or 20 mg/kg) during gestation and lactation. Maternal exposure to low doses of THC (1 and 5 mg/kg), relevant for human consumption, resulted in an increased response to the reinforcing effects of a moderate dose of morphine (350 microg/kg), as measured in the place-preference conditioning paradigm (CPP) in the adult male offspring. These animals also displayed an enhanced exploratory behavior in the defensive withdrawal test. However, only females born from mothers exposed to THC 1 mg/kg exhibited a small increment in the place conditioning induced by morphine. The possible implication of the hypothalamo-pituitary-adrenal axis (HPA) was analyzed by monitoring plasma levels of adrenocorticotropic hormone (ACTH) and corticosterone in basal and moderate-stress conditions (after the end of the CPP test). Female offspring perinatally exposed to THC (1 or 5 mg/kg) displayed high basal levels of corticosterone and a blunted adrenal response to the HPA-activating effects of the CPP test. However, male offspring born from mothers exposed to THC (1 or 5 mg/kg) displayed the opposite pattern: normal to low basal levels of corticosterone, and a sharp adrenal response to the CPP challenge. The present study reveals that maternal exposure to low doses of THC results in an increased sensitivity to the reinforcing effects of morphine in the adult male offspring, and in sexually dimorphic behavioral and endocrine alterations in the adaptative responses to stressors such as novelty or place-preference testing. These results support the growing evidence of the importance of monitoring the long-term consequences of maternal consumption of cannabis derivatives.
Instituto Universitario de Drogodependencias (Departamento de Psicobiología, Facultad de Psicología), Universidad Complutense, Madrid, Spain.
P
P
Rubio
F
F
Rodríguez de Fonseca
J L
JL
Martín-Calderón
I
I
Del Arco
S
S
Bartolomé
M A
MA
Villanúa
M
M
Navarro
D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D003213:Conditioning, Psychological / Q000187:drug effects* / Q000502:physiology; D003345:Corticosterone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000633:toxicity*; D005260:Female; D006213:Hallucinogens / Q000633:toxicity*; D007774:Lactation / Q000187:drug effects; D008297:Male; D018811:Maternal Exposure; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012054:Reinforcement, Psychology
D006213:Hallucinogens; D009294:Narcotics; D009020:Morphine; D013759:Dronabinol; D000324:Adrenocorticotropic Hormone; D003345:Corticosterone